Meet us at

Talk: Dr. Christoph Peter, Head of Quality Management

Talk: Dr. Christoph Peter, Head of Quality Management: “Quality Risk Management - Die Möglichkeit sich auf das Wesentliche zu fokussieren”

Talk: Dr. Christine Günther, CEO

Dr. Günther also participates in the press conference held at the Joint Stand of the Bavarian Biotechnology Cluster...

Talk: Dr. Christine Günther, CEO: "Gene Therapy with modified MSC to treat GI-cancer: translation into clinic and results from a phase I/II study"

Next Generation Cell Therapy

Next Generation Cell Therapy

With its unique platform technology based on adult (stem) cells apceth is one of the leading companies in research, development, manufacturing and clinical implementation of innovative cell-based therapeutics.

Clinical programs

Clinical programms

apceth is implementing innovative cell-based therapies into clinical trials of all phases and stages of development. At present patients are enrolled into a clinical trial for the treatment of advanced gastrointestinal cancer.

GMP contract manufacturing

GMP contract manufacturing

apceth provides full GCP/GMP services for cell-based biopharmaceuticals. We established a robust production process in our state-of-the-art facilities which provide a unique combination of GMP and BSL2 laboratories.